MJBizDaily
After Trulieve, which cannabis MSO will be next to uplist?
Latest Posts
Blue Dream’s revenge: Why the market needs old-school cannabis genetics
Returning to classic strains isn't about nostalgia - it's about building a scalable cannabis market.
News December 17Cannabis MSO Vireo bets on Colorado with $49 million acquisition
Cannabis MSO PharmaCann is selling some of its Colorado retail assets to Vireo Growth Inc. for $49 million in newly issued Vireo shares.
News December 17What’s next after President Trump reschedules marijuana?
Plant-touching cannabis companies would benefit from marijuana rescheduling, but it's one step on a longer reform road.
News December 17Cannabis e-commerce option is bringing industry closer to normal
A partnership between High Times and Hoodie Analytics gives retailers and brands increased visibility on the publication’s digital platform.
News December 17Conservative alarm fuels hopes President Trump will reschedule marijuana
Prominent right-wing media figures and lawmakers alike sounded the alarm over President Donald Trump's consideration of marijuana rescheduling.
News December 17Campaign to end Maine adult-use marijuana legalization cleared to begin
A ballot initiative that would end the Maine adult-use cannabis industry can begin collecting signatures.
News December 16Connecticut cannabis prices drop – but so do sales
Cannabis prices are falling in Connecticut but remain nearly double those in Massachusetts.
News December 16US Supreme Court rejects federal marijuana prohibition challenge
The nation's high court won't hear a case challenging federal marijuana laws brought by four licensed cannabis companies.
News December 15Kentucky launches medical marijuana sales as first dispensary opens
Kentucky’s first medical marijuana dispensary opened nearly a year after the first patients received recommendations.
News December 15












